top of page

Dr Wen Shi Lee

+61 3 8344 9938

Wen Shi is a postdoctoral researcher in the Kent Laboratory. He was awarded his PhD in 2019 on studies investigating whether antibodies that mediate antibody-dependent cellular cytotoxicity (ADCC) could be utilised for an HIV cure. Wen Shi continues his interest in antibody Fc effector functions and recently began characterising SARS-CoV-2 specific antibodies in people who recovered from COVID-19. 

  • Twitter
  • rg
  • orcid-og-image

Research Interests

Antibody Fc effector functions

In addition to recognising and neutralising viruses via the antigen-binding fragment (Fab), antibodies can engage innate immune cells via the Fc region and mediate a myriad of effector functions including antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent phagocytosis (ADP). 

We recently characterised ADCC and ADP responses in people who recovered from COVID-19 and found that they last longer than neutralising antibodies.

A THP-1 monocyte (blue) forming an immunological synapse with an antibody-coated target cell expressing SARS-CoV-2 spike (red)

bottom of page